Soru

Zorluk: OrtaDiagnostic and Screening Test Performance

A 2828-year-old man presents to an outpatient clinic with a 22-day history of low-grade fever, myalgias, and mild fatigue. A newly FDA-approved point-of-care rapid antigen test for a circulating respiratory virus is available. Regional epidemiologic surveillance indicates that the current prevalence of this viral infection in the community is 10%10\%. The manufacturer's validation studies report that the assay has a sensitivity of 80%80\% and a specificity of 95%95\%. The physician performs the swab, and the test yields a positive result. Based on these statistical parameters, what is the approximate probability that this patient is actually infected with the virus?

  1. A
    10%10\%
  2. B
    36%36\%
  3. 64%64\%Cevap
  4. D
    80%80\%
  5. E
    94%94\%

Cevap

The correct probability that the patient has the infection is 64%64\%.
The question asks for the Positive Predictive Value (PPV) of the test, which is the probability that a patient with a positive test truly has the disease. PPV depends on sensitivity, specificity, and the disease prevalence in the tested population.

Using a hypothetical cohort of 1,0001,000 patients:
- With a prevalence of 10%10\%, 100100 patients have the disease and 900900 do not.
- The test has 80%80\% sensitivity, meaning it will correctly identify 8080 true positives out of the 100100 diseased patients.
- The test has 95%95\% specificity, meaning its false positive rate is 5%5\%. Out of the 900900 healthy patients, 5%5\% will falsely test positive, yielding 4545 false positives.
- The total number of positive tests is 8080 (true positives) + 4545 (false positives) = 125125.

The PPV is the ratio of true positives to total positives: 80/125=0.6480 / 125 = 0.64, or 64%64\%. Therefore, the probability that the patient actually has the infection is 64%64\%.

Adım Adım Çözüm

1
Determine the true prevalence and set up a hypothetical population (e.g., 1,0001,000 people).
With a 10%10\% prevalence, there are 100100 people with the disease and 900900 people without the disease.
Applying percentages to a hypothetical cohort simplifies Bayesian calculations and helps visualize the 2×22\times2 table.
2
Calculate the number of True Positives (TP) using the test's sensitivity.
Sensitivity is 80%80\%. 80%80\% of the 100100 diseased patients will test positive. TP=80TP = 80.
Sensitivity measures the proportion of actual positives correctly identified.
3
Calculate the number of False Positives (FP) using the test's specificity.
Specificity is 95%95\%, meaning the false positive rate is 5%5\%. 5%5\% of the 900900 healthy patients will incorrectly test positive. FP=0.05×900=45FP = 0.05 \times 900 = 45.
Specificity measures the true negative rate; its complement (1−specificity1 - \text{specificity}) determines the false positive rate in the healthy population.
4
Calculate the Positive Predictive Value (PPV).
Total positive results=TP+FP=80+45=125\text{Total positive results} = TP + FP = 80 + 45 = 125. PPV=TPTotal Positives=80125=0.64\text{PPV} = \frac{TP}{\text{Total Positives}} = \frac{80}{125} = 0.64 or 64%64\%.
PPV answers the clinical question: 'Given a positive test result, what is the probability that the disease is actually present?'

Anahtar Kavram

Positive Predictive Value (PPV) depends heavily on disease prevalence and must be calculated using both the test's intrinsic characteristics (sensitivity, specificity) and the pre-test probability.

Alternatif Yöntem

This problem can also be solved rapidly using Likelihood Ratios (LR). LR+=Sensitivity1−Specificity=0.800.05=16\text{LR+} = \frac{\text{Sensitivity}}{1 - \text{Specificity}} = \frac{0.80}{0.05} = 16. The pre-test odds are calculated from prevalence: 0.100.90=19\frac{0.10}{0.90} = \frac{1}{9}. The post-test odds equal the pre-test odds multiplied by LR+\text{LR+}: 19×16=169\frac{1}{9} \times 16 = \frac{16}{9}. Finally, converting post-test odds back to probability yields 16/91+16/9=1625=64%\frac{16/9}{1 + 16/9} = \frac{16}{25} = 64\%.
Tahmini Süre:1m 30s
Bu soruyu puanla